Death receptors in liver biology and pathobiology

Hepatology

Volumn 29, Issue 1, 1999, Pages 1-4

  Faubion, William A ^a   Gores, Gregory J ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE INHIBITOR; CYTOKINE RECEPTOR; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; CELL DEATH; ENZYME INHIBITION; HUMAN; KUPFFER CELL; LIVER CELL; LIVER DISEASE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL;

ANIMALS; APOPTOSIS; CELL DEATH; HUMANS; LIVER; LIVER DISEASES; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 0032899887     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290101     Document Type: Review

References (35)

1. Golstein P. Cell death: TRAIL and its receptors. Curr Biol 1997;7:R750-753.
2. Kondo T, Suda T, Fukuyama H, Adachi M, Nagata S. Essential roles of the Fas ligand in the development of hepatitis [Comments]. Nat Med 1997;3:-409-413.
3. Strasser A, O'Connor L. Fas ligand - caught between Scylla and Charybdis [News; Comment]. Nat Med 1998;4:21-22.
4. Nagata S. Apoptosis by death factor. Cell 1997;88:355-365.
5. Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 1994;76:959-962.
6. Saile B, Knittel T, Matthes N, Schott P, Ramadori G. CD95/CD95L-mediated apoptosis of the hepatic stellate cell. A mechanism terminating uncontrolled hepatic stellate cell proliferation during hepatic tissue repair. Am J Pathol 1997;151:1265-1272.
7. Muschen M, Warskulat U, Douillard P, Gilbert E, Haussinger D. Regulation of CD95 (APO-1/Fas) receptor and ligand expression by lipopolysaccharide and dexamethasone in parenchymal and nonparenchymal rat liver cells. Hepatology 1998;27:200-208.
8. Krams SM, Fox CK, Beatty PR, Cao S, Villaneuva JC, Esquivel CO, Martinez OM. Human hepatocytes produce an isoform of FAS that inhibits apoptosis. Transplantation 1998;65:713-721.
9. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitmaura Y, Itoh N, et al. Lethal effect of the anti-Fas antibody in mice [Published erratum appears in Nature 1993 Oct 7;365(6446):568]. Nature 1993;364:806-809.
10. Adachi M, Suematsu S, Suda T, Watanabe D, Fukuyama H, Ogasawara J, Tanaka T, et al. Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc Natl Acad Sci USA 1996;93:2131-2136.
11. Mochizuki K, Hayashi N, Hiramatsu N, Katayama K, Kawanishi Y, Kasahara A, Fusamoto H, et al. Fas antigen expression in liver tissues of patients with chronic hepatitis B. J Hepatol 1996;24:1-7.
12. Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, Krammer PH, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995;182:1223-1230.
13. Hayashi N, Mita E. Fas system and apoptosis in viral hepatitis. J Gastroenterol Hepatol 1997;12:S223-S226.
14. Okazaki M, Hino K, Fujii K, Kobayashi N, Okita K. Hepatic Fas antigen expression before and after interferon therapy in patients with chronic hepatitis C. Dig Dis Sci 1996;41:2453-2458.
15. Giordano C, Stassi G, De Maria R, Todaro M, Richiusa P, Papoff G, Ruberti G, et al. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis [Comments]. Science 1997;275:960-963.
16. Ito Y, Takeda T, Umeshita K, Sakon M, Wakasa K, Matsuura N, Monden M. Fas antigen expression in hepatocellular carcinoma tissues. Oncol Reports 1998;5:41-44.
17. Muller M, Strand S, Hug H, Heinemann EM, Walczak H, Hofmann WJ, Stremmel W, et al. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest 1997;99:403-413.
18. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, Peter ME. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 1997;16:2794-2804.
19. Muzio M, Stockwell BR, Stennicke HR, Salvesen GS, Dixit VM. An induced proximity model for caspase-8 activation. J Biol Chem 1998;273:2926-2930.
20. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996;85:817-827.
21. Salvesen GS, Dixit VM. Caspases: intracellular signaling by proteolysis. Cell 1997;91:443-446.
22. Zhang J, Cado D, Chen A, Kabra NH, Winoto A. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 1998;392:296-300.
23. Hu S, Vincenz C, Ni J, Gentz R, Dixit VM, I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis. J Biol Chem 1997;272:17255-17257.
24. Lacronique V, Mignon A, Fabre M, Viollet B, Rouquet N, Molina T, Porteau A, et al. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat Med 1996;2:80-86
25. Deveraux QL, Takahashi R, Salvesen GS, Reed JC. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 1997;388:300-304.
26. Tartaglia LA, Rothe M, Hu YF, Goeddel DV. Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell 1993;73:213-216.
27. Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 1995;81:495-504.
28. Su F, Schneider RJ. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc Natl Acad Sci USA 1997;94:8744-8749.
29. Louis H, Le Moine O, Peny MO, Quertinmont E, Fokan D, Goldman M, Deviere J. Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice. Hepatology 1997;25:1382-1389.
30. Tagawa Y, Sekikawa K, Iwakura Y. Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. J Immun 1997;159:1418-1428.
31. Iimuro Y, Gallucci RM, Luster MI, Kono H, Thurman RG. Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 1997;26:1530-1537.
32. Yamada Y, Kirillova I, Peschon JJ, Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type 1 tumor necrosis factor receptor. Proc Natl Acad Sci USA 1997;94:1441-1446.
33. Leist M, Gantner F, Kunstle G, Bohlinger I, Tiegs G, Bluethmann H, Wendel A. The 55-kD tumor necrosis factor receptor and CD95 independently signal murine hepatocyte apoptosis and subsequent liver failure. Mol Med 1996;2:109-124.
34. Duan H, Dixit VM. RAIDD is a new 'death' adaptor molecule. Nature 1997;385:86-89.
35. Wu M, Ao Z, Prasad K, Wu R, Schlossman S. IEX-IL, an apoptosis inhibitor involved in NF-kappaB-Mediated cell survival. Science 1998;281:998-1001.